Protalix BioTherapeutics Inc (PLX)
1.66
-0.03
(-1.78%)
USD |
NYAM |
Nov 21, 16:00
1.65
-0.01
(-0.60%)
After-Hours: 20:00
Protalix BioTherapeutics Enterprise Value: 94.82M for Nov. 21, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 21, 2024 | 94.82M |
| November 20, 2024 | 97.03M |
| November 19, 2024 | 92.61M |
| November 18, 2024 | 94.82M |
| November 15, 2024 | 75.68M |
| November 14, 2024 | 76.41M |
| November 13, 2024 | 63.90M |
| November 12, 2024 | 69.79M |
| November 11, 2024 | 60.95M |
| November 08, 2024 | 58.01M |
| November 07, 2024 | 58.01M |
| November 06, 2024 | 62.42M |
| November 05, 2024 | 68.31M |
| November 04, 2024 | 66.84M |
| November 01, 2024 | 64.63M |
| October 31, 2024 | 58.74M |
| October 30, 2024 | 58.74M |
| October 29, 2024 | 58.74M |
| October 28, 2024 | 55.80M |
| October 25, 2024 | 52.12M |
| October 24, 2024 | 48.43M |
| October 23, 2024 | 47.70M |
| October 22, 2024 | 50.64M |
| October 21, 2024 | 50.64M |
| October 18, 2024 | 52.85M |
| Date | Value |
|---|---|
| October 17, 2024 | 52.85M |
| October 16, 2024 | 52.85M |
| October 15, 2024 | 52.12M |
| October 14, 2024 | 50.64M |
| October 11, 2024 | 52.12M |
| October 10, 2024 | 46.22M |
| October 09, 2024 | 46.96M |
| October 08, 2024 | 47.70M |
| October 07, 2024 | 47.70M |
| October 04, 2024 | 52.12M |
| October 03, 2024 | 46.96M |
| October 02, 2024 | 47.70M |
| October 01, 2024 | 49.91M |
| September 30, 2024 | 47.70M |
| September 27, 2024 | 52.61M |
| September 26, 2024 | 54.08M |
| September 25, 2024 | 55.55M |
| September 24, 2024 | 54.82M |
| September 23, 2024 | 57.76M |
| September 20, 2024 | 56.29M |
| September 19, 2024 | 59.97M |
| September 18, 2024 | 55.55M |
| September 17, 2024 | 56.29M |
| September 16, 2024 | 55.55M |
| September 13, 2024 | 52.61M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
19.45M
Minimum
Dec 03 2021
274.11M
Maximum
Feb 24 2021
91.33M
Average
82.93M
Median
Jan 04 2023
Enterprise Value Benchmarks
| Accuray Inc | 301.10M |
| Aethlon Medical Inc | -1.478M |
| AIM ImmunoTech Inc | 9.017M |
| Perspective Therapeutics Inc | -63.40M |
| Armata Pharmaceuticals Inc | 166.25M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | 3.236M |
| Revenue (Quarterly) | 17.96M |
| Total Expenses (Quarterly) | 13.97M |
| EPS Diluted (Quarterly) | 0.03 |
| Gross Profit Margin (Quarterly) | 53.37% |
| Profit Margin (Quarterly) | 18.02% |
| Earnings Yield | -9.64% |
| Normalized Earnings Yield | -9.639 |